Skip to main content
Fig. 2 | Pediatric Rheumatology

Fig. 2

From: A multi-site pilot randomized clinical trial of the Treatment and Education Approach for Childhood-onset Lupus (TEACH) program: study design and COVID-19 adaptations

Fig. 2

Study Design and Timeline. After consenting, participants will be screened for study eligibility. If eligible, participants will complete a baseline assessment and will then be randomized to TEACH + TAU or medical TAU alone. All participants will complete a post assessment approximately eight weeks after baseline. If they were randomized to TAU alone, they will be able to participate in TEACH + TAU after the post assessment is completed. An additional follow-up (20 weeks from baseline) will also be conducted with all participants

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096